| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 645 companies in the Biotechnology industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | CTRVP Hepion Pharmaceuticals, Inc. | Stetz Gary S. II | Director | Buy | 500,000 | $0.05 | $25,000.00 | New | - | - | |
| Aug 3, 2026 | CTRVP Hepion Pharmaceuticals, Inc. | Appajosyula Sireesh | Chief Operating Officer | Buy | 2,000,000 | $0.05 | $100,000.00 | +160.0% | - | - | |
| Aug 3, 2026 | MBRX Moleculin Biotech, Inc. | Klemp Walter V | CEO And President | Buy | 533,333 | $0.00 | - | +1,720% | - | - | |
| Aug 3, 2026 | CTRVP Hepion Pharmaceuticals, Inc. | Purcell Michael J. | Director | Buy | 2,000,000 | $0.05 | $100,000.00 | +160.0% | - | - | |
| Aug 3, 2026 | APMD Apnimed, Inc. | Morningside Venture Investments Ltd93 | 10% Owner | Buy | 312,500 | $16.00 | $5,000,000.00 | +4.6% | - | - | |
| Aug 3, 2026 | CTRVP Hepion Pharmaceuticals, Inc. | Lopriore Vincent S | Executive Chairman | Buy | 10,000,000 | $0.05 | $500,000.00 | +48.8% | - | - | |
| Aug 3, 2026 | SEPN Septerna, Inc. | Long Daniel D. | SVP, Drug Discovery | Sell | 3,334 | $34.47 | $114,919.89 | -1.7% | - | - | |
| Aug 3, 2026 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L72 | Chief Financial Officer | Sell | 7,500 | $95.57 | $716,771.00 | -2.5% | - | - | |
| Aug 3, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Burnett Patrick | See Remarks | Sell | 955 | $26.12 | $24,941.54 | -0.8% | - | - | |
| Aug 3, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Howe Jolanda | SVP, Global Controller | Sell | 1,840 | $105.29 | $193,733.60 | -59.1% | - | - | |
| Aug 3, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Matsuda Masaru50 | See Remarks | Sell | 1,230 | $26.12 | $32,123.66 | -1.0% | - | - | |
| Aug 3, 2026 | MBRX Moleculin Biotech, Inc. | Picker Donald H | Chief Science Officer | Buy | 173,333 | $0.00 | - | +23,019% | - | - | |
| Aug 3, 2026 | CTRVP Hepion Pharmaceuticals, Inc. | Stetz Gary S. | Interim CEO | Buy | 2,000,000 | $0.05 | $100,000.00 | +160.0% | - | - | |
| Aug 3, 2026 | NRIX Nurix Therapeutics, Inc. | Ring Christine76 | Chief Legal Officer | Sell | 16,589 | $23.05 | $382,358.20 | -64.6% | - | - | |
| Jul 31, 2026 | ANIX Anixa Biosciences, Inc. | Kumar Amit62 | Chief Executive Officer | Buy | 5,000 | $3.47 | $17,350.00 | +0.8% | - | - | |
| Jul 31, 2026 | TRDA Entrada Therapeutics, Inc. | Parmar Kush62 | Director, 10% Owner | Sell | 116,474 | $6.93 | $807,027.38 | -2.0% | - | - | |
| Jul 31, 2026 | TRDA Entrada Therapeutics, Inc. | 5am Ventures V, L.P.62 | 10% Owner | Sell | 116,474 | $6.93 | $807,027.38 | -2.0% | - | - | |
| Jul 31, 2026 | NXTC Nextcure, Inc. | Adar1 Capital Management, LLC78 | 10% Owner | Buy | 329,153 | $4.93 | $1,624,120.50 | +6.6% | - | - | |
| Jul 31, 2026 | ARTV Artiva Biotherapeutics, Inc. | Ra Capital Management, L.P.52 | Director, 10% Owner | Buy | 45,768 | $9.96 | $455,725.68 | +0.1% | - | - | |
| Jul 30, 2026 | VCEL Vericel Corporation | Siegal Jonathan64 | Principal Accounting Officer | Sell | 4,500 | $48.90 | $220,050.00 | -58.2% | - | - | |
| Jul 30, 2026 | PTIX Protagenic Therapeutics, Inc. | Armen Garo H49 | Exec. Chair &Principal Off. | Buy | 26,291 | $0.18 | $4,805.99 | New | - | - | |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | Hansen Gwenn72 | Chief Scientific Officer | Sell | 3,847 | $23.38 | $89,953.63 | -3.1% | - | - | |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | Van Houte Hans60 | Chief Financial Officer | Sell | 2,845 | $23.38 | $66,524.07 | -6.0% | - | - | |
| Jul 30, 2026 | NRIX Nurix Therapeutics, Inc. | Ring Christine76 | Chief Legal Officer | Sell | 3,847 | $23.38 | $89,953.63 | -16.2% | - | - | |
| Jul 30, 2026 | ACAD Acadia Pharmaceuticals Inc. | Thompson Elizabeth H.Z. | EVP, Head Of Research &Dev | Sell | 16,558 | $26.13 | $432,662.54 | -30.3% | - | - |